BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20581301)

  • 1. Experimental therapies and clinical trials in bone sarcoma.
    Chugh R
    J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic bone sarcomas: controversies and treatment options.
    Morris CD
    J Natl Compr Canc Netw; 2010 Jun; 8(6):731-7. PubMed ID: 20581302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.
    Dai X; Ma W; He X; Jha RK
    Med Sci Monit; 2011 Aug; 17(8):RA177-190. PubMed ID: 21804475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in primary bone tumors.
    Schwab JH; Springfield DS; Raskin KA; Mankin HJ; Hornicek FJ
    J Bone Joint Surg Am; 2012 Oct; 94(20):1913-9. PubMed ID: 23079883
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance imaging in malignant bone tumours.
    Exner GU; von Hochstetter AR; Augustiny N; von Schulthess G
    Int Orthop; 1990; 14(1):49-55. PubMed ID: 2341214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
    Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
    Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
    Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
    Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in the diagnosis and treatment of malignant bone tumors.
    Schajowicz F
    Clin Orthop Relat Res; 1983 Nov; (180):220-52. PubMed ID: 6313271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.
    van Oosterwijk JG; Anninga JK; Gelderblom H; Cleton-Jansen AM; Bovée JV
    Hematol Oncol Clin North Am; 2013 Oct; 27(5):1021-48. PubMed ID: 24093174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
    Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
    Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
    Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A
    J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone tumors].
    Madon E; Grazia G; Brach Del Prever A
    Pediatr Med Chir; 1984; 6(2):201-8. PubMed ID: 6597920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Ewing's sarcoma and osteosarcoma.
    Sharma V; Crawford AH; Evans J; Collins MH
    J Pediatr Orthop B; 2008 Nov; 17(6):333-7. PubMed ID: 18841070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric bone tumors: osteosarcoma ewing's sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis.
    Pierz KA; Womer RB; Dormans JP
    J Pediatr Orthop; 2001; 21(3):412-8. PubMed ID: 11371830
    [No Abstract]   [Full Text] [Related]  

  • 18. Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy.
    Tenardi RD; Frühwald MC; Jürgens H; Hertroijs D; Bauer J
    Pediatr Blood Cancer; 2013 Jan; 60(1):166. PubMed ID: 22997176
    [No Abstract]   [Full Text] [Related]  

  • 19. State-of-the-art approach in selective curable tumors: bone sarcoma.
    Bielack SS; Carrle D
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii155-60. PubMed ID: 18790938
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone Cancer: Diagnosis and Treatment Principles.
    Ferguson JL; Turner SP
    Am Fam Physician; 2018 Aug; 98(4):205-213. PubMed ID: 30215968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.